| Literature DB >> 27068183 |
Sydney Plummer1, Thomas Manning2, Tess Baker1, Tysheon McGreggor1, Mehulkumar Patel1, Greg Wylie3, Dennis Phillips4.
Abstract
Bryostatin-1 is a marine natural product that has demonstrated medicinal activity in pre-clinical and clinical trials for the treatment of cancer, Alzheimer's disease, effects of stroke, and HIV. In this study, iron-bryostatin-1 was obtained using a pharmaceutical aquaculture technique developed by our lab that cultivates marine bacteria for marine natural product extraction. Analytical measurements (1)H and (13)C NMR, mass spectrometry, and flame atomic absorption were utilized to confirm the presence of an iron-bryostatin-1 complex. The iron-bryostatin-1 complex produced was then tested against the National Cancer Institute's 60 cell line panel. Adding iron to bryostatin-1 lowered the anti-cancer efficacy of the compound.Entities:
Keywords: Aquaculture; Bryostatin; Bugula neritina; Cancer; Candidatus Endobugula sertula; Cell line; Iron; Synthesis
Mesh:
Substances:
Year: 2016 PMID: 27068183 DOI: 10.1016/j.bmcl.2016.03.099
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823